KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to 0.12%.

  • Gsk's Return on Capital Employed rose 300.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.05% for FY2024, which is 1300.0% down from last year.
  • According to the latest figures from Q3 2025, Gsk's Return on Capital Employed is 0.12%, which was up 300.0% from 0.09% recorded in Q2 2025.
  • Over the past 5 years, Gsk's Return on Capital Employed peaked at 0.26% during Q4 2023, and registered a low of 0.08% during Q4 2024.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.11% (2021), whereas its average is 0.12%.
  • In the last 5 years, Gsk's Return on Capital Employed surged by 700bps in 2022 and then plummeted by -1800bps in 2024.
  • Gsk's Return on Capital Employed (Quarter) stood at 0.15% in 2021, then soared by 50bps to 0.22% in 2022, then grew by 19bps to 0.26% in 2023, then tumbled by -70bps to 0.08% in 2024, then surged by 49bps to 0.12% in 2025.
  • Its Return on Capital Employed stands at 0.12% for Q3 2025, versus 0.09% for Q2 2025 and 0.09% for Q1 2025.